FDA commissioner race could test pharmaceutical industry’s sway-rollcall: A tug of war over who should lead the Food and Drug Administration at a critical moment has become a referendum on how the value of agency experience stacks up against new perspectives on how the FDA should regulate the pharmaceutical industry.
